ABL products have received multiple U.S. and international patents and government approvals, including EPA and FDA approval. Most recently, in April 2009, the U.S. Food and Drug Administration (FDA) granted ABL's ASAP Wound Dressing Gel with 510(k) medical device approval "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product utilizes ABL's innovative SilverSol Technology, which has garnered multiple patents in the U.S. and countries throughout the world, including a broad-spectrum use patent for combating many of the world's most destructive pathogens, including malaria, tuberculosis, MRSA and HIV.
ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens. Information about some of these studies is available at the research section of the ABL Website, www.americanbiotechlabs.com/researchprotected/researchmenu.html.
About American Biotech Labs
American Biotech Labs (ABL; www.americanbiotechlabs.com), founded in 1998, utilizes patented processes and SilverSol Technology(R) to create singularly powerful and effective nano-catalytic silver products. In extensive testing performed by a variety of respected laboratories and researchers, ABL's silver hydrosol has consistently demonstrated the ability, without any known toxic side effects, to destroy a wide range of bacteria, viruses, yeast, and molds. ABL products have been approved by the Environmental Protection Agency (EPA) as a disinfectant for dental water lines, and as a surface disinfectant for bacteria, yeast and mold in hospital, residential, commercial and industrial settings; and by the U.S. Food and Drug Administration (FDA) for wound management. The company's produc
|SOURCE American Biotech Labs, LLC|
Copyright©2009 PR Newswire.
All rights reserved